ReviewFrontiers in pharmacology2024

The leukotriene receptor antagonist montelukast as a potential therapeutic adjuvant in multiple sclerosis - a review.

Frank Pietrantonio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.